Mettler-Toledo International (NYSE:MTD) Earns Sector Perform Rating from Analysts at Royal Bank Of Canada

Stock analysts at Royal Bank Of Canada began coverage on shares of Mettler-Toledo International (NYSE:MTD) in a report released on Tuesday, Benzinga reports. The firm set a “sector perform” rating and a $1,515.00 price target on the medical instruments supplier’s stock. Royal Bank Of Canada’s target price indicates a potential upside of 7.75% from the company’s current price.

Other equities analysts also recently issued reports about the stock. Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Morgan Stanley boosted their price objective on Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 4th. Citigroup dropped their price objective on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. JPMorgan Chase & Co. reduced their price objective on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Finally, Wolfe Research started coverage on Mettler-Toledo International in a report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Six analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $1,465.75.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,405.98 on Tuesday. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 159.45. Mettler-Toledo International has a 1 year low of $1,023.05 and a 1 year high of $1,525.17. The company has a market cap of $28.18 billion, a PE ratio of 31.64, a PEG ratio of 2.88 and a beta of 1.23. The stock’s 50-day moving average price is $1,350.11 and its two-hundred day moving average price is $1,274.33.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.78 by $0.68. The business had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.03 billion. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The firm’s revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $10.09 earnings per share. On average, analysts predict that Mettler-Toledo International will post 47.35 EPS for the current year.

Insider Buying and Selling

In related news, insider Gerry Keller sold 240 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total transaction of $342,513.60. Following the completion of the transaction, the insider owned 259 shares in the company, valued at approximately $369,629.26. The trade was a 48.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shawn Vadala sold 2,240 shares of the firm’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total value of $3,207,680.00. Following the sale, the chief financial officer directly owned 5,579 shares in the company, valued at approximately $7,989,128. This represents a 28.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 4,254 shares of company stock valued at $6,092,712 over the last 90 days. 0.71% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. XXEC Inc. bought a new stake in Mettler-Toledo International during the second quarter worth $77,044,000. California State Teachers Retirement System boosted its stake in shares of Mettler-Toledo International by 114,807.7% during the 2nd quarter. California State Teachers Retirement System now owns 35,100,865 shares of the medical instruments supplier’s stock worth $44,841,706,000 after acquiring an additional 35,070,318 shares during the period. BlackRock Inc. acquired a new position in shares of Mettler-Toledo International during the 2nd quarter worth approximately $2,404,713,000. Bank of New York Mellon Corp acquired a new position in shares of Mettler-Toledo International in the second quarter valued at $762,553,000. Finally, Wellington Management Group LLP raised its position in shares of Mettler-Toledo International by 908.6% in the second quarter. Wellington Management Group LLP now owns 459,064 shares of the medical instruments supplier’s stock valued at $586,459,000 after purchasing an additional 413,547 shares during the period. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.